Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 60.98 USD 2.21% Market Closed
Market Cap: 11.1B USD
Have any thoughts about
Catalent Inc?
Write Note

Relative Value

The Relative Value of one CTLT stock under the Base Case scenario is 85.36 USD. Compared to the current market price of 60.98 USD, Catalent Inc is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CTLT Relative Value
Base Case
85.36 USD
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
71
vs Industry
44
Median 3Y
2.5
Median 5Y
2.9
Industry
2.5
Forward
2.3
vs History
vs Industry
0
Median 3Y
22.2
Median 5Y
38.4
Industry
21.9
Forward
54.5
vs History
84
vs Industry
10
Median 3Y
40.5
Median 5Y
37.8
Industry
16.5
vs History
vs Industry
Median 3Y
19.8
Median 5Y
-16.3
Industry
23.6
vs History
58
vs Industry
27
Median 3Y
2.8
Median 5Y
3.3
Industry
2.1
vs History
71
vs Industry
31
Median 3Y
3.5
Median 5Y
3.9
Industry
2.6
Forward
3.3
vs History
36
vs Industry
10
Median 3Y
14.1
Median 5Y
14.9
Industry
5.2
vs History
11
vs Industry
4
Median 3Y
23.6
Median 5Y
23.2
Industry
13.3
Forward
18.9
vs History
vs Industry
11
Median 3Y
25.6
Median 5Y
32.4
Industry
16.6
Forward
30.7
vs History
74
vs Industry
7
Median 3Y
53.7
Median 5Y
45
Industry
15.6
vs History
11
vs Industry
Median 3Y
-54.5
Median 5Y
-99.2
Industry
19.1
vs History
58
vs Industry
42
Median 3Y
1.6
Median 5Y
1.8
Industry
1.9

Multiples Across Competitors

CTLT Competitors Multiples
Catalent Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Catalent Inc
NYSE:CTLT
11B USD 2.5 -26.7 35.3 -324.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
Catalent Inc
NYSE:CTLT
Average P/E: 32.4
Negative Multiple: -26.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top